Otrivin Ukonserveret nasal spray

Otrivin is a well-known brand of decongestant nasal spray containing xylometazoline hydrochloride, used to relieve nasal congestion caused by colds or sinusitis. The brand was originally created by the Swiss pharmaceutical giant Ciba (later Ciba-Geigy and Novartis).

Through corporate restructuring and joint ventures between Novartis and GlaxoSmithKline (GSK), consumer healthcare brands including Otrivin became part of GSK Consumer Healthcare. In 2022, this business was spun off into an independent publicly traded company called Haleon plc, headquartered in Weybridge, Surrey, United Kingdom.

Otrivin nasal sprays distributed in Europe, including Denmark, are primarily manufactured at Haleon's specialized pharmaceutical manufacturing facilities in Nyon, Switzerland.